TrialJournal of neurology2012
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS.
Bianca Weinstock-Guttman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled ittrialcites it